Shopping Cart 0
Cart Subtotal
AED 0

Symic Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company's pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft failure. Symic Biomedical's SB-061 is a clinical candidate used for disease modification and pain management in the treatment of osteoarthritis. The company also has applications in the areas of fibrosis and oncology. It partners with various pharmaceutical company for the clinical development of osteoarthritis program. Symic Biomedical is headquartered in Emeryville, California, the US.

Symic Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Symic Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Symic Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Symic Biomedical Raises USD30 Million in Series B Venture Financing 11

Symic Biomedical Raises USD25 Million in Series A-2 Financing 12

Symic Biomedical Raises USD15 Million in Series A Financing 13

Symic Biomedical Raises USD0.53 Million in Extended Venture Financing 14

Symic Biomedical Raises USD 0.8 Million In Venture Financing 15

Partnerships 16

Symic Biomedical Enters into Co-Development Agreement with Nordic Bioscience 16

Symic Biomedical Inc - Key Competitors 17

Symic Biomedical Inc - Key Employees 18

Symic Biomedical Inc - Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Corporate Communications 20

Jan 30, 2017: Symic Bio Appoints Scott W. Morrison to Board of Directors 20

Product News 21

05/18/2017: Symic Bio Announces Results from MODIFY-OA Trial of SB-061 for the Treatment of Osteoarthritis of the Knee 21

02/24/2017: Symic Bio Announces Last Patient Enrolled in SHIELD Trial of SB-030 for Interventions in Peripheral Artery Disease 22

Clinical Trials 23

Apr 16, 2018: Results from Symic Bio Liver Fibrosis Program Presented at the International Liver Congress 2018 23

Aug 23, 2017: Symic Bio Enrolls First Patient in MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Osteoarthritis 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Symic Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Symic Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Symic Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Symic Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Symic Biomedical Raises USD30 Million in Series B Venture Financing 11

Symic Biomedical Raises USD25 Million in Series A-2 Financing 12

Symic Biomedical Raises USD15 Million in Series A Financing 13

Symic Biomedical Raises USD0.53 Million in Extended Venture Financing 14

Symic Biomedical Raises USD 0.8 Million In Venture Financing 15

Symic Biomedical Enters into Co-Development Agreement with Nordic Bioscience 16

Symic Biomedical Inc, Key Competitors 17

Symic Biomedical Inc, Key Employees 18

Symic Biomedical Inc, Other Locations 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Symic Biomedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company's pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft failure. Symic Biomedical's SB-061 is a clinical candidate used for disease modification and pain management in the treatment of osteoarthritis. The company also has applications in the areas of fibrosis and oncology. It partners with various pharmaceutical company for the clinical development of osteoarthritis program. Symic Biomedical is headquartered in Emeryville, California, the US.

Symic Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Symic Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Symic Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Symic Biomedical Raises USD30 Million in Series B Venture Financing 11

Symic Biomedical Raises USD25 Million in Series A-2 Financing 12

Symic Biomedical Raises USD15 Million in Series A Financing 13

Symic Biomedical Raises USD0.53 Million in Extended Venture Financing 14

Symic Biomedical Raises USD 0.8 Million In Venture Financing 15

Partnerships 16

Symic Biomedical Enters into Co-Development Agreement with Nordic Bioscience 16

Symic Biomedical Inc - Key Competitors 17

Symic Biomedical Inc - Key Employees 18

Symic Biomedical Inc - Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Corporate Communications 20

Jan 30, 2017: Symic Bio Appoints Scott W. Morrison to Board of Directors 20

Product News 21

05/18/2017: Symic Bio Announces Results from MODIFY-OA Trial of SB-061 for the Treatment of Osteoarthritis of the Knee 21

02/24/2017: Symic Bio Announces Last Patient Enrolled in SHIELD Trial of SB-030 for Interventions in Peripheral Artery Disease 22

Clinical Trials 23

Apr 16, 2018: Results from Symic Bio Liver Fibrosis Program Presented at the International Liver Congress 2018 23

Aug 23, 2017: Symic Bio Enrolls First Patient in MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Osteoarthritis 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Symic Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Symic Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Symic Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Symic Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 9

Symic Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Symic Biomedical Raises USD30 Million in Series B Venture Financing 11

Symic Biomedical Raises USD25 Million in Series A-2 Financing 12

Symic Biomedical Raises USD15 Million in Series A Financing 13

Symic Biomedical Raises USD0.53 Million in Extended Venture Financing 14

Symic Biomedical Raises USD 0.8 Million In Venture Financing 15

Symic Biomedical Enters into Co-Development Agreement with Nordic Bioscience 16

Symic Biomedical Inc, Key Competitors 17

Symic Biomedical Inc, Key Employees 18

Symic Biomedical Inc, Other Locations 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Symic Biomedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.